Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check4 days agoChange DetectedOn 2026-09-29, the history adds new Contacts/Locations and Study Status sections to the study record; on 2026-09-26, entries labeled 349 and 350 were added to the history.SummaryDifference0.1%

- Check11 days agoChange DetectedOn 2026-09-23, the record history adds entries for Contacts/Locations and Study Status (with a 2026-09-22 reference and the number 348), and an entry dated 2026-09-11 was removed. This reflects updated site information and the latest status in the study's record history.SummaryDifference0.1%

- Check18 days agoChange DetectedThe history view adds navigation labels such as Find contact information, Contacts/Locations, and Study Status, and shows a site revision to Revision: v3.7.0, while removing the older Find Contact Information label and Revision: v3.6.6.SummaryDifference0.2%

- Check26 days agoChange DetectedOn 2026-09-02, the record history adds Contacts/Locations and the Study Status sections. These additions reveal who to contact for the study and the current status of the trial.SummaryDifference0.1%

- Check33 days agoChange DetectedA new revision entry (v3.6.6) was added to the study history on 2026-09-01, introducing the Study Status and Contacts/Locations sections and listing new entries 342 and 343.SummaryDifference0.1%

- Check40 days agoChange DetectedA new update on 2026-08-21 adds Contacts/Locations and Study Status to the record history (along with a related 2026-08-20 entry and the item '341'). An entry dated 2026-08-04 was removed.SummaryDifference0.1%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.